SCHEMBL20172279

SCHEMBL20172279

Cc1ccc(OCc2cnccn2)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
MAPK1 P28482 2/20 0.49
KMT2A Q03164 2/20 0.49
TP53 P04637 1/20 0.49
HTT P42858 1/20 0.49
MRGPRX4 Q96LA9 2/20 0.47
RAB9A P51151 5/20 0.43
L3MBTL1 Q9Y468 5/20 0.43
MAPT P10636 4/20 0.43
ATM Q13315 2/20 0.43
ERBB2 P04626 2/20 0.43
SYK P43405 3/20 0.43
EGFR P00533 2/20 0.42
NPC1 O15118 4/20 0.41
HPGD P15428 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
GAA P10253 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11961091 0.85 L3MBTL1 (0.51) MAPK1KMT2AHTTMRGPRX4RAB9A
SCHEMBL29944991 0.82 SYK (0.52) MRGPRX4RAB9AERBB2SYKEGFR
SCHEMBL12524878 0.82 MRGPRX4 (0.50) MEN1MAPK1KMT2ATP53HTT
SCHEMBL2702047 0.82 SYK (0.52) MRGPRX4RAB9AERBB2SYKEGFR
SCHEMBL29945002 0.82 SYK (0.52) MRGPRX4RAB9AERBB2SYKEGFR
SCHEMBL15932954 0.82 ERBB2 (0.46) MRGPRX4RAB9AATMERBB2SYK
SCHEMBL15701536 0.82 RXRA (0.50) MRGPRX4RAB9AERBB2SYKEGFR
SCHEMBL2760112 0.81 SYK (0.59) MEN1MAPK1KMT2ATP53HTT
SCHEMBL17858634 0.78 MRGPRX4 (0.55) MEN1MAPK1KMT2ATP53HTT
SCHEMBL27299184 0.78 SYK (0.48) MEN1MAPK1KMT2ATP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2680850-B1 ALKYNE SUBSTITUTED QUINAZOLINE COMPOUND AND METHODS OF USE NEWGEN THERAPEUTICS INC (US) 2018-05-23 EP disclosed